Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PLA2G7 | Q13093 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28484755 | 1.00 | LMNA (0.48) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL10797604 | 0.81 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL113602 | 0.81 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL113601 | 0.81 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL9709937 | 0.75 | LMNA (0.57) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL1797266 | 0.71 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL11211452 | 0.71 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL28901973 | 0.71 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL1797264 | 0.71 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A | |
| SCHEMBL11211453 | 0.71 | LMNA (0.52) | LMNAL3MBTL1PLA2G7NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7790759-B2 | Glycyrrhetinic acid-30-amide derivatives and their use | TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) | 2010-09-07 | — | — | US | disclosed |
| EP-1935892-B1 | GLYCYRRHETINIC ACID-30-AMIDE DERIVATIVES AND THE USES THEREOF | TIANJIN INST PHARM RESEARCH (CN) | 2010-08-11 | — | — | EP | disclosed |
| US-20080214636-A1 | Glycyrrhetinic Acid-30-Amide Derivatives and Their Use | TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) | 2008-09-04 | — | — | US | disclosed |
| EP-1935892-A1 | GLYCYRRHETINIC ACID-30-AMIDE DERIVATIVES AND THE USES THEREOF | TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) | 2008-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214636-A1 | Glycyrrhetinic Acid-30-Amide Derivatives and Their Use | IL36G, CYP26A1, IL17A | LMNA 3220/4885L3MBTL1 4690/4885PLA2G7 1579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.